NIH-funded research NIH-funded research

Using N-acetylcysteine to reduce repetitive behaviors in children with autism

Official title: Targeting the neurobiology of restricted and repetitive behaviors in children with autism using N-acetylcysteine

Funded at Stanford University · NIH-11014325 · Data updated 2026-11-12

This study is looking at whether a nutritional supplement called N-acetylcysteine (NAC) can help reduce certain repetitive behaviors in children with autism, and it involves brain scans and a 12-week trial to see how well it works.

More Autism research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startFebruary 1, 2023
Project endJanuary 31, 2026
Funding year2025
Award (this year)$248,999
NIH project number5R00HD101702-05
Project IDNIH-11014325 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children aged 0-11 years diagnosed with autism spectrum disorder who exhibit severe restricted and repetitive behaviors.

Less likely to help

Patients who do not have autism spectrum disorder or do not exhibit significant restricted and repetitive behaviors may not benefit from this research.

What this research studies

This research investigates how N-acetylcysteine (NAC), a nutritional supplement, can help reduce restricted and repetitive behaviors (RRB) in children with autism spectrum disorder (ASD). The study will involve collecting brain imaging data and conducting a randomized controlled trial to assess the effectiveness of NAC over 12 weeks. By examining how NAC affects brain signaling, researchers aim to understand its potential benefits for children exhibiting severe RRB. The ultimate goal is to support the development of new treatment options for children with ASD.

Why it matters

Potential benefit: If successful, this research could provide a new, effective treatment option for reducing challenging behaviors in children with autism.

How similar studies have gone: Preliminary trials have shown that N-acetylcysteine may effectively reduce the severity of restricted and repetitive behaviors in children with autism, indicating potential for success in this research.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Hegarty, John Patrick — Stanford University
  • Study coordinator: Hegarty, John Patrick

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.